206 related articles for article (PubMed ID: 34686346)
1. Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis.
Duan S; Moro L; Qu R; Simoneschi D; Cho H; Jiang S; Zhao H; Chang Q; de Stanchina E; Arbini AA; Pagano M
Cell Rep; 2021 Oct; 37(3):109870. PubMed ID: 34686346
[TBL] [Abstract][Full Text] [Related]
2. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract][Full Text] [Related]
3. Degradation of FBXO31 by APC/C is regulated by AKT- and ATM-mediated phosphorylation.
Choppara S; Malonia SK; Sankaran G; Green MR; Santra MK
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):998-1003. PubMed ID: 29343641
[TBL] [Abstract][Full Text] [Related]
4. FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation.
Zou S; Ma C; Yang F; Xu X; Jia J; Liu Z
Mol Cancer Res; 2018 Feb; 16(2):286-295. PubMed ID: 29117943
[TBL] [Abstract][Full Text] [Related]
5. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling.
Scheufele F; Wolf B; Kruse M; Hartmann T; Lempart J; Mühlich S; Pfeiffer AFH; Field LJ; Charron MJ; Pan ZQ; Engelhardt S; Sarikas A
Cell Signal; 2014 Feb; 26(2):233-239. PubMed ID: 24219910
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.
Carver BS; Chapinski C; Wongvipat J; Hieronymus H; Chen Y; Chandarlapaty S; Arora VK; Le C; Koutcher J; Scher H; Scardino PT; Rosen N; Sawyers CL
Cancer Cell; 2011 May; 19(5):575-86. PubMed ID: 21575859
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages.
Molina G; Vogt A; Bakan A; Dai W; Queiroz de Oliveira P; Znosko W; Smithgall TE; Bahar I; Lazo JS; Day BW; Tsang M
Nat Chem Biol; 2009 Sep; 5(9):680-7. PubMed ID: 19578332
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional regulation of the DUSP6/MKP-3 phosphatase by MEK/ERK signaling and hypoxia.
Bermudez O; Jouandin P; Rottier J; Bourcier C; Pagès G; Gimond C
J Cell Physiol; 2011 Jan; 226(1):276-84. PubMed ID: 20665674
[TBL] [Abstract][Full Text] [Related]
10. The SCF
Choppara S; Ganga S; Manne R; Dutta P; Singh S; Santra MK
J Biol Chem; 2018 Oct; 293(42):16291-16306. PubMed ID: 30171069
[TBL] [Abstract][Full Text] [Related]
11. SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication.
Johansson P; Jeffery J; Al-Ejeh F; Schulz RB; Callen DF; Kumar R; Khanna KK
J Biol Chem; 2014 Jun; 289(26):18514-25. PubMed ID: 24828503
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
Feng S; Shao L; Castro P; Coleman I; Nelson PS; Smith PD; Davies BR; Ittmann M
Oncotarget; 2017 Jan; 8(4):6179-6192. PubMed ID: 28008155
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
15. KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling.
He W; Zhang MG; Wang XJ; Zhong S; Shao Y; Zhu Y; Shen ZJ
Int J Clin Exp Pathol; 2013; 6(12):2864-71. PubMed ID: 24294372
[TBL] [Abstract][Full Text] [Related]
16. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
17. Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cells.
Lee JT; Steelman LS; Chappell WH; McCubrey JA
Cell Cycle; 2008 Mar; 7(5):631-6. PubMed ID: 18256541
[TBL] [Abstract][Full Text] [Related]
18. Calcium saccharate/DUSP6 suppresses renal cell carcinoma glycolytic metabolism and boosts sunitinib efficacy via the ERK-AKT pathway.
Liu H; Wang L; Shi X; Yin L; Zhai W; Gao S; Chen Y; Zhang T
Biochem Pharmacol; 2024 Jun; 224():116247. PubMed ID: 38697311
[TBL] [Abstract][Full Text] [Related]
19. F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 (MKK6).
Liu J; Han L; Li B; Yang J; Huen MS; Pan X; Tsao SW; Cheung AL
J Biol Chem; 2014 Aug; 289(31):21508-18. PubMed ID: 24936062
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
